XENT - インタ―セクトENT （Intersect ENT Inc.）XENTのニュース
First Financial Bank Selects RiskExec® SaaS Platform for Fair Lending Compliance 2022/08/16 14:00:00 Kwhen Finance
With the FTC''s conditional approval, Medtronic completes its $1.1B acquisition of Intersect ENT - MedCity News 2022/05/13 17:16:52 MedCity News
To get approval for the deal, Medtronic agreed to sell an Intersect subsidiary to soothe the FTC''s concerns.
Medtronic closes on deal to acquire Intersect ENT 2022/05/13 15:42:23 Star Tribune
The announcement came one day after the Federal Trade Commission imposed conditions on the acquisition
Medtronic makes FTC-mandated sale to close Intersect ENT deal, and scores FDA nod to boot 2022/05/13 15:21:32 FierceBiotech
Medtronic makes FTC-mandated sale to close Intersect ENT deal, and scores FDA nod to boot apark Fri, 05/13/2022 - 11:21
Intersect ENT gains after receiving U.S. antitrust approval for sale to Medtronic 2022/05/09 22:36:35 Seeking Alpha
Intersect ENT (XENT) rose 1.2% in after hours trading after the Federal Trade Commission on Monday granted early termination under the HSR waiting period for its planned sale to…
First Financial Bank Selects RiskExec® SaaS Platform for Fair Lending Compliance 2022/08/16 14:00:00 Kwhen Finance
With the FTC''s conditional approval, Medtronic completes its $1.1B acquisition of Intersect ENT - MedCity News 2022/05/13 17:16:52 MedCity News
To get approval for the deal, Medtronic agreed to sell an Intersect subsidiary to soothe the FTC''s concerns.
Medtronic closes on deal to acquire Intersect ENT 2022/05/13 15:42:23 Star Tribune
The announcement came one day after the Federal Trade Commission imposed conditions on the acquisition
Medtronic makes FTC-mandated sale to close Intersect ENT deal, and scores FDA nod to boot 2022/05/13 15:21:32 FierceBiotech
Medtronic makes FTC-mandated sale to close Intersect ENT deal, and scores FDA nod to boot apark Fri, 05/13/2022 - 11:21
Intersect ENT gains after receiving U.S. antitrust approval for sale to Medtronic 2022/05/09 22:36:35 Seeking Alpha
Intersect ENT (XENT) rose 1.2% in after hours trading after the Federal Trade Commission on Monday granted early termination under the HSR waiting period for its planned sale to…
With the FTC''s conditional approval, Medtronic completes its $1.1B acquisition of Intersect ENT - MedCity News 2022/05/13 17:16:52 MedCity News
To get approval for the deal, Medtronic agreed to sell an Intersect subsidiary to soothe the FTC''s concerns.
Medtronic closes on deal to acquire Intersect ENT 2022/05/13 15:42:23 Star Tribune
The announcement came one day after the Federal Trade Commission imposed conditions on the acquisition
Medtronic makes FTC-mandated sale to close Intersect ENT deal, and scores FDA nod to boot 2022/05/13 15:21:32 FierceBiotech
Medtronic makes FTC-mandated sale to close Intersect ENT deal, and scores FDA nod to boot apark Fri, 05/13/2022 - 11:21
Intersect ENT gains after receiving U.S. antitrust approval for sale to Medtronic 2022/05/09 22:36:35 Seeking Alpha
Intersect ENT (XENT) rose 1.2% in after hours trading after the Federal Trade Commission on Monday granted early termination under the HSR waiting period for its planned sale to…
The Global ENT Handheld Instruments Market to Observe Immense Growth with a CAGR of 6.36% by 2026, Assesses DelveInsight 2022/04/28 17:00:00 Benzinga
New York, USA, April 28, 2022 (GLOBE NEWSWIRE) -- The Global ENT Handheld Instruments Market to Observe Immense Growth with a CAGR of 6.36% by 2026, Assesses DelveInsight As per DelveInsight Analysis in ENT Handheld Instruments market, the increasing prevalence of aging population and the associated hearing loss along with the rising disposable income and rising affordability for ENT treatment are some of the key factors that are responsible for the growth of ENT Handheld Instruments market. According to the latest report published by DelveInsight " ENT Handheld Instruments Market Insight ," the global ENT Handheld Instruments market is expected to witness remarkable growth owing to the rising prevalence of chronic disorders, rising number of surgical procedures coupled with technological advancements, and the surge in the geriatric population. Furthermore, the rise in robot-assisted surgical procedures along with the rising prevalence of lifestyle diseases will also be responsible for an increase in the ENT Handheld Instruments market growth.